A Winning Diagnostic

In a new report, consulting company McKinsey says diagnostics companies will have to combine advanced analysis of genomic data with electronic medical records, effective reimbursement strategies, and full data-regulatory compliance in order to make the most out of a personalized medicine market that is expected to reach $140 billion in value by 2026. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.